| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD.
Address correspondence and reprint requests to Dr. V. Chaudhry, 600 N. Wolfe Street, Mey 6-119, Baltimore, MD 21287; e-mail: vchaudh{at}jhmi.edu
The authors report the use mycophenolate mofetil (MM) in the treatment of neuromuscular diseases. Thirty-eight patients (32 with MG, three with inflammatory myopathy, and three with chronic acquired demyelinating neuropathy) were treated with MM for an average duration of 12 months. All patients tolerated MM without major side effects. Twenty-four patients improved either in their functional status or in their ability to reduce corticosteroid dose. Mean time to improvement was 5 months.
This article has been cited by other articles:
|
|
 |
|
  M. Benatar and L. P. Rowland The muddle of mycophenolate mofetil in myasthenia Neurology, August 5, 2008; 71(6): 390 - 391. [Full Text] [PDF]
|
|
|
|
|
|
The Muscle Study Group A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis Neurology, August 5, 2008; 71(6): 394 - 399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Sanders, I. K. Hart, R. Mantegazza, S. S. Shukla, Z. A. Siddiqi, M.H.V. De Baets, A. Melms, M. W. Nicolle, N. Solomons, and D. P. Richman An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis Neurology, August 5, 2008; 71(6): 400 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M P J Garssen, R van Koningsveld, and P A van Doorn Treatment of Guillain Barre syndrome with mycophenolate mofetil: a pilot study J. Neurol. Neurosurg. Psychiatry, September 1, 2007; 78(9): 1012 - 1013. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Piepers, R. Van den Berg-Vos, W-L. Van der Pol, H. Franssen, J. Wokke, and L. Van den Berg Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial Brain, August 1, 2007; 130(8): 2004 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zinman, E. Ng, and V. Bril IV immunoglobulin in patients with myasthenia gravis: A randomized controlled trial Neurology, March 13, 2007; 68(11): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. N. Pisoni, M. J. Cuadrado, M. A. Khamashta, G. R. V. Hughes, and D. P. D'Cruz Mycophenolate mofetil treatment in resistant myositis Rheumatology, March 1, 2007; 46(3): 516 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A C Cordeiro and D A Isenberg Treatment of inflammatory myopathies. Postgrad. Med. J., July 1, 2006; 82(969): 417 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rowin, A. A. Amato, N. Deisher, J. Cursio, and M. N. Meriggioli Mycophenolate mofetil in dermatomyositis: Is it safe? Neurology, April 25, 2006; 66(8): 1245 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D Cahoon Jr and D. R Kockler Mycophenolate Mofetil Treatment of Myasthenia Gravis Ann. Pharmacother., February 1, 2006; 40(2): 295 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Koller, B. C. Kieseier, S. Jander, and H.-P. Hartung Chronic Inflammatory Demyelinating Polyneuropathy N. Engl. J. Med., March 31, 2005; 352(13): 1343 - 1356. [Full Text] [PDF]
|
|
|
|
 |
|
 P Vermersch, T Stojkovic, and J de Seze Mycophenolate mofetil and neurological diseases Lupus, March 1, 2005; 14(3_suppl): s42 - s45. [Abstract] [PDF]
|
|
|
|
|
|
E Ciafaloni Mycophenolate mofetil and myasthenia gravis Lupus, March 1, 2005; 14(3_suppl): s46 - s49. [Abstract] [PDF]
|
|
|
|
|
|
P. Vermersch, T. Stojkovic, and J. de Seze Mycophenolate mofetil and neurological diseases Lupus, January 1, 2005; 14(1_suppl): s42 - s45. [Abstract] [PDF]
|
|
|
|
|
|
E. Ciafaloni Mycophenolate mofetil and myasthenia gravis Lupus, January 1, 2005; 14(1_suppl): s46 - s49. [Abstract] [PDF]
|
|
|
|
 |
|
 M. J. Kothari Myasthenia Gravis J Am Osteopath Assoc, September 1, 2004; 104(9): 377 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Gorson, A. A. Amato, and A. H. Ropper Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy Neurology, August 24, 2004; 63(4): 715 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Richman and M. A. Agius Treatment of autoimmune myasthenia gravis Neurology, December 23, 2003; 61(12): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.N. Meriggioli, E. Ciafaloni, K.A. Al-Hayk, J. Rowin, B. Tucker-Lipscomb, J.M. Massey, and D.B. Sanders Mycophenolate mofetil for myasthenia gravis: An analysis of efficacy, safety, and tolerability Neurology, November 25, 2003; 61(10): 1438 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Korn, K. Toyka, H.-P. Hartung, and S. Jung Suppression of experimental autoimmune neuritis by leflunomide Brain, September 1, 2001; 124(9): 1791 - 1802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Mycophenolate Mofetil: A New Immunosuppressant in Neuromuscular Disease? Journal Watch Neurology, March 28, 2001; 2001(328): 2 - 2. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
